Foxo Technologies Inc
FOXO1.570USD
+0.933+146.82%
Cierre 05/09, 16:00（ET）Cotizaciones retrasadas 15 min
36.99MCap. mercado
--P/E TTM
Más Datos de Foxo Technologies Inc Compañía
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Información de la empresa
Código de la empresaFOXO
Nombre de la empresaFoxo Technologies Inc
Fecha de salida a bolsaDec 11, 2020
Fundada en2020
Director ejecutivoMr. Seamus Lagan
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 11
Dirección477 South Rosemary Avenue
CiudadWEST PALM BEACH
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal33401
Teléfono16128000059
Sitio Webhttp://delwinds.com/
Código de la empresaFOXO
Fecha de salida a bolsaDec 11, 2020
Fundada en2020
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
333.00
-60.02%
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Martin C. Ward
Mr. Martin C. Ward
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
333.00
-60.02%
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Martin C. Ward
Mr. Martin C. Ward
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Accionista
Hora de actualización: vie., 9 de may
Hora de actualización: vie., 9 de may
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
Clearthink Capital Partners LLC
1.53%
GWG Wind Down Trust
1.18%
Kr8 ai Inc
0.60%
UBS Financial Services, Inc.
0.36%
Jane Street Capital, L.L.C.
0.30%
Other
96.03%
Estadísticas de accionistas
Accionista
Proporción
Clearthink Capital Partners LLC
1.53%
GWG Wind Down Trust
1.18%
Kr8 ai Inc
0.60%
UBS Financial Services, Inc.
0.36%
Jane Street Capital, L.L.C.
0.30%
Other
96.03%
Tipo
Accionista
Proporción
Corporation
3.31%
Investment Advisor
0.64%
Research Firm
0.47%
Investment Advisor/Hedge Fund
0.46%
Hedge Fund
0.07%
Other
95.05%
Participación institucional
Hora de actualización: lun., 3 de mar
Hora de actualización: lun., 3 de mar
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
44
297.90K
11.61%
-32.78K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
2023Q2
124
2.96M
79.90%
-804.39K
2023Q1
129
1.99M
69.67%
-1.77M
2022Q4
123
1.73M
63.52%
-18.64M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Clearthink Capital Partners LLC
600.00K
2.55%
+600.00K
--
Dec 01, 2023
GWG Wind Down Trust
464.67K
1.97%
+464.67K
--
Aug 11, 2023
Kr8 ai Inc
237.04K
1.01%
--
--
Nov 14, 2024
UBS Financial Services, Inc.
139.89K
0.59%
+139.89K
--
Dec 31, 2024
Jane Street Capital, L.L.C.
117.05K
0.5%
+117.05K
--
Dec 31, 2024
Sabby Management, LLC
80.56K
0.34%
+80.56K
--
Dec 31, 2024
SBI Securities Co., Ltd.
39.33K
0.17%
+39.33K
--
Dec 31, 2024
Geode Capital Management, L.L.C.
42.46K
0.18%
--
--
Dec 31, 2024
Corbin Capital Partners, L.P.
27.48K
0.12%
--
--
Dec 31, 2024
Susquehanna International Group, LLP
27.23K
0.12%
-76.72K
-73.81%
Dec 31, 2024
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Fecha
Tipo
Relación
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1